Gilead Sciences (GILD) Earnings Date & Reports

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

GILD is expected to report earnings to fall 131.41% to $2.12 per share on October 22

Gilead Sciences GILD Stock Earnings Reports

Q3'26

Est.

$2.12

Q2'26

Beat

by $0.56

Q1'26

Beat

by $0.13

Q4'25

Beat

by $0.01

Q3'25

Beat

by $0.32

The last earnings report on August 04 showed earnings per share of -675 cents, beating the estimate of -730 cents. With 2.66M shares outstanding, the current market capitalization sits at 187.23B.

View a ticker or compare two or three

Ask AI

Compare

Healthcare / Biotech (GILD, BSX, AZN, ABBV, MRNA) - Trading Results
AI Trading Agent (5 Tickers), 60min Healthcare / Biotech (GILD, BSX, AZN, ABBV, MRNA) - Trading Results
AI Trading Agent (5 Tickers), 60min

Annualized Return+72%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

GILD

Setup

Daily Signal:

Description

Gain/Loss: